Spirax Group (SPX) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
13 Jun, 2025Economic environment
Industrial production growth remained weak in Q3, with key markets underperforming forecasts.
Global IP (excluding China) forecast for 2024 was revised down to 0.9% from 1.5%.
Macroeconomic conditions in China continue to be challenging.
Trading performance
Group organic sales growth for the ten months to 31 October exceeded first half levels, with all three businesses growing year-on-year, excluding currency effects.
Steam Thermal Solutions returned to organic sales growth, though large orders in China remained weak; MRO sales grew.
Electric Thermal Solutions saw higher organic sales growth, driven by increased shipments and operational improvements.
Watson-Marlow's Biopharm sales were supported by a normalizing order book, while process industries sales growth improved.
Financial position
Net borrowings (excluding leases) at 31 October were £642 million, down from £718 million at 30 June.
Net debt to EBITDA ratio improved to 1.7x from 1.9x at 30 June.
Latest events from Spirax Group
- Organic growth, margin expansion, and strong cash flow support further progress in 2026.SPX
H2 202510 Mar 2026 - Organic sales up, reported revenue down; full-year growth and margin stability expected.SPX
H1 20242 Feb 2026 - Organic growth and margin ahead of H1, with full year outlook reaffirmed and net debt reduced.SPX
Trading update22 Jan 2026 - Organic growth outpaced industrial production, with margin stability and a 3% dividend increase.SPX
H2 202422 Jan 2026 - Decarbonization, digitalization, and operational excellence drive growth and margin expansion.SPX
CMD 202419 Jan 2026 - Organic growth and margin expansion support an unchanged full-year outlook despite headwinds.SPX
H1 202523 Nov 2025 - Low single-digit organic growth and 2025 guidance maintained amid macro uncertainty.SPX
Trading update6 Jun 2025